SCHEMBL5717067

SCHEMBL5717067

COc1ccc2c(c1)cc(C(=O)NO)c1nnnn12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.43
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
POLB P06746 1/20 0.42
HDAC6 Q9UBN7 4/20 0.42
HDAC1 Q13547 3/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
HPGD P15428 3/20 0.41
MAPT P10636 2/20 0.41
EGFR P00533 1/20 0.41
ERBB2 P04626 1/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 2/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5101900 0.91 ALDH1A1 (0.43) KDM4EALDH1A1SMN1; SMN2POLBHDAC6
SCHEMBL5102439 0.80 MEN1 (0.51) KDM4EALDH1A1SMN1; SMN2HDAC6HDAC1
SCHEMBL5115361 0.79 MAPT (0.43) L3MBTL1KDM4EALDH1A1SMN1; SMN2POLB
SCHEMBL4499753 0.77 ALDH1A1 (0.45) KDM4EALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL5102600 0.76 HDAC6 (0.37) KDM4EHDAC6HDAC1KMT2AGAA
SCHEMBL5139069 0.75 MAPT (0.42) L3MBTL1KDM4EALDH1A1SMN1; SMN2MEN1
SCHEMBL4499121 0.74 CUL4A (0.49) KDM4EALDH1A1HDAC6HDAC1MEN1
SCHEMBL4500138 0.72 KDM4E (0.46) L3MBTL1KDM4EALDH1A1SMN1; SMN2MEN1
SCHEMBL5101860 0.72 ALDH1A1 (0.42) L3MBTL1KDM4EALDH1A1SMN1; SMN2HDAC6
SCHEMBL5114538 0.71 TACR1 (0.40) POLBHDAC6HDAC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1668009-A1 HCV INHIBITORS AND METHODS OF USING THEM Rigel Pharmaceuticals, Inc. (US) 2006-06-14 EP claimed
WO-2005030774-A1 HCV INHIBITORS AND METHODS OF USING THEM RIGEL PHARMACEUTICALS, INC. (US) 2005-04-07 WO claimed